Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellen F M 't Hoen

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Lancet (London, England)|May 31, 2016
Indian hepatitis C drug patent decision shakes public health communityEllen F M 't Hoen
Lancet (London, England)|January 24, 2007
Compensation for diethylstilbestrol injuryEllen F M 't Hoen, M N Graham Dukes
Journal of Pharmaceutical Policy and Practice|December 8, 2018
Patent challenges in the procurement and supply of generic new essential medicines and lessons from HIV in the southern African development community (SADC) regionEllen F M 't Hoen, Tapiwanashe Kujinga, Pascale Boulet
Journal of Pharmaceutical Policy and Practice|July 4, 2017
Data exclusivity exceptions and compulsory licensing to promote generic medicines in the European Union: <i>A proposal for greater coherence in European pharmaceutical legislation</i>Ellen F M 't Hoen, Pascale Boulet, Brook K Baker
Journal of Public Health Policy|January 17, 2014
A quiet revolution in global public health: The World Health Organization's Prequalification of Medicines ProgrammeEllen F M 't Hoen, Hans V Hogerzeil, Jonathan D Quick, et al.
Lancet (London, England)|November 24, 2015
Essential medicines are still essentialAndy L Gray, Veronika J Wirtz, Ellen F M 't Hoen, et al.
BMC Medicine|October 10, 2018
Pathways to ensure universal and affordable access to hepatitis C treatmentCaitlin H Douglass, Alisa Pedrana, Jeffrey V Lazarus, et al.
Lancet (London, England)|November 12, 2016
Essential medicines for universal health coverageVeronika J Wirtz, Hans V Hogerzeil, Andrew L Gray, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Lancet (London, England)|May 31, 2016
Indian hepatitis C drug patent decision shakes public health communityEllen F M 't Hoen
Lancet (London, England)|January 24, 2007
Compensation for diethylstilbestrol injuryEllen F M 't Hoen, M N Graham Dukes
Journal of Pharmaceutical Policy and Practice|December 8, 2018
Patent challenges in the procurement and supply of generic new essential medicines and lessons from HIV in the southern African development community (SADC) regionEllen F M 't Hoen, Tapiwanashe Kujinga, Pascale Boulet
Journal of Pharmaceutical Policy and Practice|July 4, 2017
Data exclusivity exceptions and compulsory licensing to promote generic medicines in the European Union: <i>A proposal for greater coherence in European pharmaceutical legislation</i>Ellen F M 't Hoen, Pascale Boulet, Brook K Baker
Journal of Public Health Policy|January 17, 2014
A quiet revolution in global public health: The World Health Organization's Prequalification of Medicines ProgrammeEllen F M 't Hoen, Hans V Hogerzeil, Jonathan D Quick, et al.
Lancet (London, England)|November 24, 2015
Essential medicines are still essentialAndy L Gray, Veronika J Wirtz, Ellen F M 't Hoen, et al.
BMC Medicine|October 10, 2018
Pathways to ensure universal and affordable access to hepatitis C treatmentCaitlin H Douglass, Alisa Pedrana, Jeffrey V Lazarus, et al.
Lancet (London, England)|November 12, 2016
Essential medicines for universal health coverageVeronika J Wirtz, Hans V Hogerzeil, Andrew L Gray, et al.
Pageof 1